PSME1

proteasome activator subunit 1, the group of Proteasome

Basic information

Region (hg38): 14:24136163-24138967

Links

ENSG00000092010NCBI:5720OMIM:600654HGNC:9568Uniprot:Q06323AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PSME1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSME1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
15
clinvar
15
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 16 1 0

Variants in PSME1

This is a list of pathogenic ClinVar variants found in the PSME1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-24137191-G-A not specified Uncertain significance (Jan 02, 2024)3220471
14-24137192-A-G not specified Uncertain significance (Jan 22, 2025)3784474
14-24137324-C-G not specified Uncertain significance (Oct 09, 2024)3427040
14-24137376-C-T not specified Uncertain significance (Jul 14, 2021)2226452
14-24137414-C-T not specified Uncertain significance (Dec 01, 2022)2401682
14-24137415-G-A not specified Uncertain significance (May 02, 2024)3311021
14-24137421-A-C not specified Uncertain significance (Nov 17, 2022)2326430
14-24137740-G-T Likely benign (Feb 01, 2023)2644129
14-24138109-G-A not specified Uncertain significance (Mar 31, 2023)2532072
14-24138242-G-C not specified Uncertain significance (Oct 04, 2022)2316397
14-24138251-C-T not specified Uncertain significance (Nov 07, 2023)3220472
14-24138259-T-G not specified Uncertain significance (May 08, 2024)3311022
14-24138358-C-T not specified Uncertain significance (Nov 26, 2024)3427042
14-24138484-G-A not specified Uncertain significance (Jun 06, 2022)2294169
14-24138484-G-C not specified Uncertain significance (Aug 12, 2021)2243884
14-24138528-C-T not specified Uncertain significance (Dec 21, 2023)3220473
14-24138549-C-T not specified Uncertain significance (Dec 21, 2023)3220474
14-24138640-G-C not specified Uncertain significance (Mar 31, 2023)2517221

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PSME1protein_codingprotein_codingENST00000382708 102810
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1320.8641257360121257480.0000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5201181350.8740.000007621647
Missense in Polyphen2742.3590.6374560
Synonymous0.6004449.40.8910.00000240453
Loss of Function2.50414.20.2826.18e-7189

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009040.0000904
Ashkenazi Jewish0.000.00
East Asian0.0001630.000109
Finnish0.000.00
European (Non-Finnish)0.00006150.0000615
Middle Eastern0.0001630.000109
South Asian0.000.00
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Implicated in immunoproteasome assembly and required for efficient antigen processing. The PA28 activator complex enhances the generation of class I binding peptides by altering the cleavage pattern of the proteasome.;
Pathway
Antigen processing and presentation - Homo sapiens (human);Proteasome - Homo sapiens (human);Proteasome Degradation;Post-translational protein modification;Metabolism of proteins;UCH proteinases;Neddylation;Ub-specific processing proteases;Deubiquitination (Consensus)

Recessive Scores

pRec
0.112

Intolerance Scores

loftool
0.885
rvis_EVS
0.28
rvis_percentile_EVS
71.27

Haploinsufficiency Scores

pHI
0.391
hipred
Y
hipred_score
0.503
ghis
0.495

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.984

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Psme1
Phenotype
neoplasm;

Gene ontology

Biological process
positive regulation of endopeptidase activity;protein deubiquitination;antigen processing and presentation of exogenous antigen;post-translational protein modification;regulation of proteasomal protein catabolic process;regulation of G1/S transition of mitotic cell cycle
Cellular component
proteasome complex;nucleoplasm;cytoplasm;cytosol;proteasome activator complex;extracellular exosome
Molecular function
protein binding;endopeptidase activator activity